Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC Advises Against Studying Nano-Products In Humans Until Risks Are Known

This article was originally published in The Tan Sheet

Executive Summary

Researchers should avoid clinical studies on nano-based personal care products until more is known about their long-term effects, according to the European Commission

You may also be interested in...



Euro nano opinion

The European Food Safety Authority's Scientific Committee opens for comment Oct. 17 a draft scientific opinion on the potential risks of nanotechnologies for food. The opinion, requested by the European Commission to help develop appropriate legislation, says that established risk assessment approaches apply to nanoscience, though "it is generally not possible to extrapolate the potential toxicity of [engineered nanomaterials] from information on dissolved or macroscale chemicals." EFSA will accept comments until Dec. 1 at 1www.efsa.europa.eu/. The EC advised European Union members to avoid clinical research on nanoparticles in food and personal care products until it learns more about their biological and environmental effects (2"The Tan Sheet" Feb. 25, 2008, p. 12)

Euro nano opinion

The European Food Safety Authority's Scientific Committee opens for comment Oct. 17 a draft scientific opinion on the potential risks of nanotechnologies for food. The opinion, requested by the European Commission to help develop appropriate legislation, says that established risk assessment approaches apply to nanoscience, though "it is generally not possible to extrapolate the potential toxicity of [engineered nanomaterials] from information on dissolved or macroscale chemicals." EFSA will accept comments until Dec. 1 at 1www.efsa.europa.eu/. The EC advised European Union members to avoid clinical research on nanoparticles in food and personal care products until it learns more about their biological and environmental effects (2"The Tan Sheet" Feb. 25, 2008, p. 12)

Euro nano opinion

The European Food Safety Authority's Scientific Committee opens for comment Oct. 17 a draft scientific opinion on the potential risks of nanotechnologies for food. The opinion, requested by the European Commission to help develop appropriate legislation, says that established risk assessment approaches apply to nanoscience, though "it is generally not possible to extrapolate the potential toxicity of [engineered nanomaterials] from information on dissolved or macroscale chemicals." EFSA will accept comments until Dec. 1 at 1www.efsa.europa.eu/. The EC advised European Union members to avoid clinical research on nanoparticles in food and personal care products until it learns more about their biological and environmental effects (2"The Tan Sheet" Feb. 25, 2008, p. 12)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel